Atara Biotherapeutics (ATRA) Inventory Average (2023 - 2024)
Atara Biotherapeutics' (ATRA) quarterly Inventory Average came in at $12.3 million in Q4 2024, up 51.16% YoY from $8.1 million in Q1 2024, and down 24.73% on a QoQ basis from $16.4 million in Q3 2024.
Atara Biotherapeutics (ATRA) Inventory Average (2023 - 2024) Analysis & Trends
Atara Biotherapeutics (ATRA) has 2 years of Inventory Average data on file, last reported at $12.3 million in Q4 2024.
- Quarterly Inventory Average rose 51.16% year-over-year to $12.3 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $12.3 million (up 51.16% YoY) and the FY2024 annual result came in at $10.2 million, up 80.31% from the prior year.
- Inventory Average retreated to $12.3 million in Q4 2024, from $16.4 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $17.4 million in Q2 2024 to a low of $3.5 million in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 90.57 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 137.65 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 196.36 Mn |
| 10 | Atara Biotherapeutics | 140.71 Mn | 124.16 Mn | 439,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 12.32 Mn |
| Sep 30, 2024 | 16.36 Mn |
| Jun 30, 2024 | 17.42 Mn |
| Mar 31, 2024 | 12.90 Mn |
| Dec 31, 2023 | 8.15 Mn |
| Sep 30, 2023 | 7.23 Mn |
| Jun 30, 2023 | 6.60 Mn |
| Mar 31, 2023 | 3.46 Mn |